Innospec (IOSP) Receives Media Impact Score of 0.25

News stories about Innospec (NASDAQ:IOSP) have trended positive on Friday, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Innospec earned a news sentiment score of 0.25 on Accern’s scale. Accern also assigned news coverage about the specialty chemicals company an impact score of 48.9766082009593 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

These are some of the news articles that may have impacted Accern Sentiment Analysis’s scoring:

Several research firms have recently issued reports on IOSP. Zacks Investment Research cut shares of Innospec from a “hold” rating to a “strong sell” rating in a research report on Friday. BidaskClub cut shares of Innospec from a “hold” rating to a “sell” rating in a research report on Thursday, January 25th. Johnson Rice raised shares of Innospec from a “hold” rating to an “accumulate” rating in a research report on Tuesday, November 14th. Monness Crespi & Hardt cut shares of Innospec from a “buy” rating to a “neutral” rating in a research report on Thursday, November 9th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Innospec in a research report on Thursday, November 9th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $70.50.

Shares of Innospec (NASDAQ IOSP) opened at $68.25 on Friday. Innospec has a one year low of $54.10 and a one year high of $74.30. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.34 and a current ratio of 2.15. The company has a market cap of $1,641.21, a price-to-earnings ratio of 27.19 and a beta of 1.07.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.47 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.13 by $0.34. Innospec had a net margin of 4.73% and a return on equity of 15.57%. The firm had revenue of $353.80 million for the quarter. analysts predict that Innospec will post 4.3 earnings per share for the current fiscal year.

In related news, VP Philip John Boon sold 501 shares of Innospec stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $67.04, for a total transaction of $33,587.04. Following the sale, the vice president now directly owns 35,439 shares in the company, valued at approximately $2,375,830.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Catherine Hessner sold 707 shares of Innospec stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $71.56, for a total transaction of $50,592.92. Following the sale, the vice president now owns 25,791 shares in the company, valued at $1,845,603.96. The disclosure for this sale can be found here. Insiders have sold a total of 8,075 shares of company stock worth $578,194 over the last quarter. 2.02% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: This story was first published by BBNS and is the property of of BBNS. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://baseballnewssource.com/markets/innospec-iosp-receives-media-impact-score-of-0-25/1908610.html.

Innospec Company Profile

Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.

Insider Buying and Selling by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish


Leave a Reply

 
© 2006-2018 BBNS.